POULTRY 
The coccidosis vaccine
Coccidosis is a common protozoan disease of domestic birds and other poultry, characterised by enteritis and bloody diarrhoea.
What is coccidiosis ?
What is Immucox ?
IMMUCOX® is designed to administer uniformly low doses of live oocysts to chickens to promote the development of immunity to coccidiosis. When administered as directed, IMMUCOX® 3 can prevent coccidiosis mortality.
Immucox®3 is a live oral coccidiosis vaccine for Broilers, that contains sporulated oocysts of :
- Eimeria acervulina
- Eimeria maxima
- Eimeria tenella
A unique coccidiosis vaccine that perfectly balances the safety and efficacy needed for broilers that are raised without antibiotics and anticoccidial resistance management programs.
Immucox® 3
Immucox®5 is a Live oral coccidiosis vaccine for Breeders & Layers , that contains sporulated oocysts of :
- Eimeria acervulina
- Eimeria maxima
- Eimeria tenella
- Eimeria necatrix
- Eimeria brunetti
A unique coccidiosis vaccine that perfectly balances safety and efficacy, in a gel droplet to prevent economic losses caused by coccidiosis in long-living birds.
Immucox® 5
Immucox®T is a live oral coccidiosis vaccine for Turkeys, that contains sporulated oocysts of :
- Eimeria adenoides
- Eimeria meleagremitis
A unique coccidiosis vaccine that perfectly balances the safety and efficacy needed for Turkeys that are raised without antibiotics and anticoccidial resistance management programs.
Immucox® T
What are the benefits of Immucox?
- Effective vaccination against coccidiosis caused by 3 species of Eimeria of economic importance to broilers
- Application of gel droplets keeps oocysts in suspension during application, preventing oocyst sedimentation and facilitating uniform absorption of all species included in the vaccine.
- Offers a natural, cost-effective alternative to anticoccidials.
Immucox administration
1. Safety & Efficacy
IMMUCOX® is formulated to induce strong and fast protective immunity against coccidiosis.
The IMMUCOX® difference begins with its safety and efficacy.
- The ingestion of an optimum number of full-cycle oocysts efficiently induces fast development of a robust immune response.
- Its unique formulation allows safe vaccine cycling.
2. Consistency
IMMUCOX® is formulated to ensure minimal variation in the oocyst viability and infectivity during its shelf life.
Vaccine’s consistency is achieved by its unique formulation and viability of oocysts at production.
3. Vaccine uptake
IMMUCOX® is applied with state-of-the-art equipment, Desvac Duo, and CevaGel technology.
The CevaGel® formulation and innovative delivery system ensure a more uniform oocyst distribution and optimized vaccine uptake.
Monitoring the disease
Monitoring for coccidiosis in chickens and turkeys is carried out by routine assessment of intestinal lesions, usually between 18 and 28 days of age. The most widely used system for monitoring coccidia is the commonly accepted Johnson and Reid scoring system. This system assigns scores from 1 to 4 (zero for a normal appearance of the intestine) for each of the five species of coccidia likely to induce lesions in chickens. A similar system has been developed for turkeys by ANSES, France. Visible lesions of the intestinal mucosa generally appear at the end of schizogony or during gamogony, and their severity remains constant for a few days. Lesions are caused by the release of merozoites and possibly unsporulated oocysts. Note: a lesion of 3, for example, is not the result of a lesion of 2 the previous day and will not progress to a different severity the following day in the same bird. The lesion observed is a direct indication of the level of challenge when the bird ingested infective oocysts 4-6 days earlier. However, as the epithelium regenerates, lesions disappear slowly, making it more difficult to establish an accurate score.